Cargando…

Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management

Pancreatic cancer is one of the dreaded malignancies for both the patient and the clinician. The five-year survival rate of pancreatic adenocarcinoma (PDA) is as low as 2% despite multimodality treatment even in the best hands. As per the Global Cancer Observatory of the International Agency for Res...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Nikhil, Yelamanchi, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218366/
https://www.ncbi.nlm.nih.gov/pubmed/34163104
http://dx.doi.org/10.3748/wjg.v27.i23.3158